On November 5, Medline Inc. rose 15.42% in Regular Trading, trading at $39.33 per share, with turnover of $219 million.
The move followed the company’s latest quarterly results, which exceeded market expectations on both profit and revenue and provided the clearest near-term catalyst for the stock’s strength.
For the quarter ended September 26, adjusted EPS was $0.44, above consensus estimates of $0.35 and $0.34 in market reports. Net sales reached $7.856 billion, ahead of expectations of $7.723 billion and up from $7.12 billion a year earlier. The revenue increase points to continued growth across its medical-surgical products and supply chain solutions businesses, helping drive the sharp advance in the shares.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments